In the sprawling landscape of U.S. healthcare, a silent crisis unfolds every day as hundreds of thousands of patients suffer preventable harm or even death due to medical errors, positioning patient safety as an urgent public health challenge that demands immediate attention. With medical errors
The vaccine industry in the United States finds itself at a critical juncture, where an unprecedented level of bipartisan support offers a glimmer of hope amid swirling controversies, technological debates, and regulatory uncertainties that could shape its future trajectory. A recent poll conducted
In a landscape where millions of patients with advanced chronic kidney disease (CKD) struggle with limited and often burdensome treatment options, a groundbreaking development has emerged to potentially transform their lives. Opterion Health AG, a clinical-stage biopharmaceutical company
What if a single policy change could jeopardize decades of progress in safeguarding children from a silent, deadly virus, and what would be the consequences of such a shift? The debate over delaying the hepatitis B vaccine from birth to age 4 has erupted into a heated controversy, pitting public
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the industry. Today, we’re diving into a pressing topic: the potential connection between processed red
In an era where access to reliable health information can make a significant difference in public safety, South Korea's Ministry of Food and Drug Safety is taking bold steps to enhance its digital resources for medical devices. With millions of people relying on accurate data to make informed
